Angiotensin converting enzyme and angiotensin II type I receptor polymorphisms in patients with coronary aneurysms

Thrombosis Journal

Volumn 1, Issue , 2003, Pages

  Lamblin, Nicolas ^a,b   Hermant, Xavier ^a   Lablanche, Jean Marc ^b   Helbecque, Nicole ^a   Amouyel, Philippe ^a,b   Bauters, Christophe ^a,b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR TYPE 1; CYTOSINE; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HYPOTHESIS; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; RANDOMIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 4344636056     PISSN: 14779560     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-9560-1-5     Document Type: Article

References (35)

1. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzales MF, Allegrini J and Bloch C: Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet 1988, 43(5):774-80.
2. Rigat B, Hubert C, Corvol P and Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992, 20(6):1433-.
3. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P and Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86(4):1343-6.
4. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L and Ricard S et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359(6396):641-4.
5. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J and Hennekens CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995, 332(11):706-11.
6. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR and Johnson AL: Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989, 165(1):196-203.
7. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P and Soubrier F: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994, 24(1):63-9.
8. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F and Ducimetiere P et al.: Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994, 344(8927):910-3.
9. Steeds RP, Wardle A, Smith PD, Martin D, Channer KS and Samani NJ: Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction. Atherosclerosis 2001, 154(1):123-8.
10. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995, 91(11):2844-50.
11. Davies MJ: Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture. Circulation 1995, 94(8):2013-20.
12. Amant C, Hamon M, Bauters C, Richard F, Helbecque N, McFadden EP, Escudero X, Lablanche JM, Amouyel P and Bertrand ME: The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997, 29(3):486-90.
13. Hamon M, Bauters C, Amant C, McFadden EP, Helbecque N, Lablanche JM, Bertrand ME and Amouyel P: Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation 1995, 92(3):296-9.
14. Amant C, Bauters C, Bodart JC, Lablanche JM, Grollier G, Danchin N, Hamon M, Richard F, Helbecque N, McFadden EP, Amouyel P and Bertrand ME: D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 1997, 96(1):56-60.
15. Daugherty A, Manning MW and Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000, 105(11):1605-12.
16. Manning MW, Cassi LA, Huang J, Szilvassy SJ and Daugherty A: Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med 2002, 7(1):45-54.
17. Dubey RK, Jackson EK and Luscher TF: Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotids and angiotensin 1 receptors. J Clin Invest 1995, 96(1):141-9.
18. Xie B, Laouar A and Huberman E: Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-alpha via alpha5 beta1 integrin in HL-60 cells. J Biol Chem 1998, 273(19):11583-8.
19. Manning MW, Cassis LA and Daugherty A: Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2003, 23(3):483-8.
20. Befeler B, Aranda MJ, Embi A, Mullin FL, El-Sherif N and Lazzara R: Coronary artery aneurysms: study of the etiology, clinical course and effect on left ventricular function and prognosis. Am J Med 1977, 62(4):597-607.
21. Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp HG, Mudd JG and Gosselin AJ: Aneurysmal coronary artery disease. Circulation 1983, 67(1):134-8.
22. Virmani R, Robinowitz M, Atkinson JB, Forman MB, Silver MD and McAllister HA: Acquired coronary arterial aneurysms: an autopsy study of 52 patients. Hum Pathol 1986, 17(6):575-83.
23. Demopoulos VP, Olympios CD, Fakiolas CN, Pissimissis EG, Economides NM, Adamopoulou E, Foussas SG and Cokkinos DV: The natural history of aneurysmal coronary artery disease. Heart 1997, 78(2):136-41.
24. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N and Amouyel P: Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 2002, 40(1):43-8.
25. Sudhir K, Ports TA, Amidon TM, Goldberger JJ, Bhushan V, Kane JP, Yock P and Malloy MJ: Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. Circulation 1995, 91(5):1375-80.
26. Reiber JH, van der Zwet PM, Koning G, von Land CD, van Meurs B, Gerbrands JJ, Buis B and van Voorthuisen AE: Accuracy and precision of quantitative digital coronary arteriography: observer-, short-, and medium-term variabilities. Cathet Cardiovasc Diagn 1993, 28(3):187-98.
27. Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
28. Nishijo N, Sugiyama F, Kimoto K, Taniguchi K, Murakami K, Suzuki S, Fukamizu A and Yagami K: Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II. Lab Invest 1998, 78(9):1059-66.
29. Huang W, Alhenc Gelas F and Osborne-Pellegrin MJ: Protection of the arterial internal elastic lamina by inhibition of the reninangiotensin system in the rat. Circ Res 1998, 82(8):879-90.
30. Liao S, Miralles M, Kelley BJ, Curci JA, Borhani M and Thompson RW: Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001, 33(5):1057-64.
31. Hamano K, Ohishi M, Ueda M, Fujioka K, Katoh T, Zempo N, Fujimura Y, Okamura A, Rakugi H, Higaki J, Ogihara T and Esato K: Deletion polymorphism in the gene for angiotensin-converting enzyme is not a risk factor predisposing to abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 1999, 18(2):158-61.
32. Pola R, Gaetani E, Santoliquido A, Gerardino L, Cattani P, Serricchio M, Tondi P, Flore R, Grande M, Carbonin P, Fadda G and Pola P: Abdominal aortic aneurysm in normotensive patients: association with angiotensin-converting enzyme gene polymorphism. Eur J Vasc Endovasc Surg 2001, 21(5):445-9.
33. Maehara A, Mintz GS, Ahmed JM, Fuchs S, Castagna MT, Pichard AD, Satler LF, Waksman R, Suddath WO, Kent KM and Weissman NJ: An intravascular ultrasound classification of angiographic coronary artery aneurysms. Am J Cardiol 2001, 88(4):365-70.
34. Ribichini F, Steffenino G, Dellavalle A, Matullo G, Colajanni E, Camilla T, Vado A, Benetton G, Uslenghi E and Piazza A: Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation 1998, 97(2):147-54.
35. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA and Leon MB: Arterial remodeling after coronary angioplasty: a serial intravascular untrasound study. Circulation 1996, 94(1):35-43.